Self-reported use of novel psychoactive substances among attendees of electronic dance music venues

References

• Watson K. An annual study of the Electronic Music industry. IMS Business Report 2015.
   Google Scholar
• Anderson TL, Kavanaugh PR. A “rave” review; conceptual interests and analytical shifts in research on rave culture. Soc Compass 2007;1:499–519.
   Google Scholar
• Ridpath A, Driver CR, Nolan ML, Karpati A, Kass D, Paone D, Jakubowski A, Hoffman RS, Nelson LS, Kunins HV, Centers for Disease Control and Prevention. Illnesses and deaths among persons attending an electronic dance-music festival - New York City, 2013. Morb Mortal Wkly Rep 2014;63:1195–1198.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Griffin-Tomas M, Ompad DC. Illicit drug use among rave attendees in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015a;152:24–31.
   PubMed Web of Science ®Google Scholar
• Kelly BC, Parsons JT, Wells BE. Prevalence and predictors of club drug use among club-going young adults in New York City. J Urban Health 2006;83:884–95.
   PubMed Web of Science ®Google Scholar
• Ross MW, Mattison AM, Franklin DR Jr. Club drugs and sex on drugs are associated with different motivations for gay circuit party attendance in men. Subst Use Misuse 2003;38:1173–1183.
   PubMed Web of Science ®Google Scholar
• European Monitoring Centre for Drugs and Drug Addiction. New psychoactive substances in Europe. An update from the EU Early Warning System (March 2015). Luxembourg: Publications Office of the European Union; 2015.
   Google Scholar
• US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System: Year 2014 Annual Report. Springfield, VA: US Drug Enforcement Administration; 2015.
   Google Scholar
• US Drug Enforcement Administration, Office of Diversion Control. National Forensic Laboratory Information System Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2010–2013. Springfield, VA: US Drug Enforcement Administration; 2014.
   Google Scholar
• American Association of Poison Control Centers. Bath salts data 2015a. January 19, 2016.
   Google Scholar
• American Association of Poison Control Centers. Synthetic cannabinoids data. 2015b. January 19, 2016.
   Google Scholar
• Palamar JJ, Su MK, Hoffman RS. Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011–2014. Am J Drug Alcohol Abuse 2016;42:39–47.
   Google Scholar
• Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future national survey results on drug use, 1975–2014: Vol. I, Secondary school students. Ann Arbor, MI: Institute for Social Research, The University of Michigan; 2015.
   Google Scholar
• Palamar JJ, Acosta P. Synthetic cannabinoid use in a nationally representative sample of US high school seniors. Drug Alcohol Depend 2015;149:194–202.
   PubMed Web of Science ®Google Scholar
• Palamar JJ. “Bath salt” use among a nationally representative sample of high school seniors in the United States. Am J Addict 2015;24:488–491.
   Google Scholar
• Home Office. Drug Misuse: Findings from the 2014/15 Crime Survey for England and Wales, Statistical Bulletin 03/15, Second edition, July 2015.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings [NSDUH Series H-48, HHS Publication No. (SMA) 14-4863]. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
   Google Scholar
• Palamar JJ, Martins SS, Su MK, Ompad DC. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting. Drug Alcohol Depend 2015b;156:112–119.
   PubMed Web of Science ®Google Scholar
• Zawilska JB, Andrzejczak D. Next generation of novel psychoactive substances on the horizon - A complex problem to face. Drug Alcohol Depend 2015;157:1–17.
   PubMed Web of Science ®Google Scholar
• Gurney SM, Scott KS, Kacinko SL, Presley BC, Logan BK. Pharmacology, toxicology, and adverse effects of synthetic cannabinoid drugs. Forensic Sci Rev 2014;26:53–78.
   PubMedGoogle Scholar
• Nugteren-van Lonkhuyzen JJ1, van Riel AJ, Brunt TM, Hondebrink L. Pharmacokinetics, pharmacodynamics and toxicology of new psychoactive substances (NPS): 2C-B, 4-fluoroamphetamine and benzofurans. Drug Alcohol Depend 2015;157:18–27.
   Google Scholar
• Tittarelli R, Mannocchi G, Pantano F, Romolo FS. Recreational use, analysis and toxicity of tryptamines. Curr Neuropharmacol 2015;13:26–46.
   PubMed Web of Science ®Google Scholar
• Kyriakou C, Marinelli E, Frati P, Santurro A, Afxentiou M, Zaami S, Busardo FP. NBOMe: new potent hallucinogens–pharmacology, analytical methods, toxicities, fatalities: A review. Eur Rev Med Pharmacol Sci 2015;19:3270–3281.
   PubMed Web of Science ®Google Scholar
• Rogers S. Which drugs do you take? US and the UK compared by the Global Drug Survey. The Guardian, 2012, March 14.
   Google Scholar
• Wood DM, Hunter L, Measham F, Dargan PI. Limited use of novel psychoactive substances in South London nightclubs. QJM. 2012;105:959–964.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kawsar A, Ramsey J, Dargan PI, Wood DM. Monitoring trends in recreational drug use from the analysis of the contents of amnesty bins in gay dance clubs. QJM. 2013;106:1111–1117.
   PubMed Web of Science ®Google Scholar
• Wallace JM Jr, Vaughn MG, Bachman JG, O’Malley PM, Johnston LD, Schulenberg JE. Race/ethnicity, socioeconomic factors, and smoking among early adolescent girls in the United States. Drug Alcohol Depend 2009;104:S42–S49.
   PubMed Web of Science ®Google Scholar
• O’Brien K, Chatwin C, Jenkins C, Measham F. New psychoactive substances and British drug policy: A view from the cyber-psychonauts. Drugs Edu Prev Policy 2015;22:217–223.
   Web of Science ®Google Scholar
• Heeringa SG, West BT. Applied survey data analysis. Berglund, PA: Chapman & Hall/CRC; 2010.
   Google Scholar
• Palamar JJ, Ompad DC. Demographic and socioeconomic correlates of powder cocaine and crack use among high school seniors in the United States. Am J Drug Alcohol Abuse 2014;40:37–43.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Shearston JA, Dawson EW, Mateu-Gelabert P, Ompad DC. Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors. Drug Alcohol Depend 2016;158:132–138.
   Google Scholar
• Degenhardt L. Drug use and risk behaviour among regular ecstasy users: Does sexuality make a difference? Cult Health Sex 2005;7:599–614.
   PubMed Web of Science ®Google Scholar
• Bauer GR, Jairam JA, Baidoobonso SM. Sexual health, risk behaviors, and substance use in heterosexual-identified women with female sex partners: 2002 US National Survey of Family Growth. Sex Transm Dis 2010;37:531–537.
   PubMed Web of Science ®Google Scholar
• Corliss HL, Rosario M, Wypij D, Wylie SA, Frazier AL, Austin SB. Sexual orientation and drug use in a longitudinal cohort study of U.S. adolescents. Addict Behav 2010;35:517–521.
   PubMed Web of Science ®Google Scholar
• Newcomb ME, Birkett M, Corliss HL, Mustanski B. Sexual orientation, gender, and racial differences in illicit drug use in a sample of US high school students. Am J Public Health 2014;104:304–310.
   PubMed Web of Science ®Google Scholar
• Roxburgh A, Lea T, de Wit J, Degenhardt L. Sexual identity and prevalence of alcohol and other drug use among Australians in the general population. Int J Drug Policy 2015; [Epub ahead of print].
   Google Scholar
• Rosenbaum CD, Carreiro SP, Babu KM. Here today, gone tomorrow … and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines. J Med Toxicol 2012;8:15–32.
   PubMedGoogle Scholar
• Sutherland R, Peacock A, Whittaker E, Roxburgh A, Lenton S, Matthews A, Butler K, Nelson M, Burns L, Bruno R. New psychoactive substance use among regular psychostimulant users in Australia, 2010–2015. Drug Alcohol Depend 2016;161:110–118.
   Google Scholar
• Carhart-Harris RL, King LA, Nutt DJ. A web-based survey on mephedrone. Drug Alcohol Depend 2011;118:19–22.
   PubMed Web of Science ®Google Scholar
• Hondebrink L, Nugteren-van Lonkhuyzen JJ, Van Der Gouwe D, Brunt TM. Monitoring new psychoactive substances (NPS) in The Netherlands: Data from the drug market and the Poisons Information Centre. Drug Alcohol Depend 2015;147:109–115.
   PubMed Web of Science ®Google Scholar
• Tanner-Smith EE. Pharmacological content of tablets sold as “ecstasy”: Results from an online testing service. Drug Alcohol Depend 2006;83:247–254.
   PubMed Web of Science ®Google Scholar
• Vogels N, Brunt TM, Rigter S, van Dijk P, Vervaeke H, Niesink RJ. Content of ecstasy in the Netherlands: 1993–2008. Addiction 2009;104:2057–2066.
   PubMed Web of Science ®Google Scholar
• Abrahamsson T, Hakansson A. Correlates of ecstasy use in the Swedish general population. Subst Use & Misuse 2013;48:353–357.
   PubMed Web of Science ®Google Scholar
• Smirnov A, Najman JM, Hayatbakhsh R, Plotnikova M, Wells H, Legosz M, Kemp R. Young adults’ trajectories of Ecstasy use: A population based study. Addictive Behav 2013a;38:2667–2674.
   PubMed Web of Science ®Google Scholar
• Martins SS, Storr CL, Alexandre PK, Chilcoat HD. Do adolescent ecstasy users have different attitudes towards drugs when compared to marijuana users? Drug and Alcohol Depend 2008a;94:63–72.
   PubMed Web of Science ®Google Scholar
• Smirnov A, Najman JM, Hayatbakhsh R, Wells H, Legosz M, Kemp R. Young adults’ recreational social environment as a predictor of ecstasy use initiation: Findings of a population-based prospective study. Addiction 2013b;108:1809–1817.
   PubMed Web of Science ®Google Scholar
• Vervaeke HK, Benschop A, van den Brink W, Korf DJ. Predicting ecstasy use among young people at risk: A prospective study of initially ecstasy-naive subjects. J Drug Educ 2008;38:131–146.
   PubMed Web of Science ®Google Scholar
• Jenness SM, Neaigus A, Murrill CS, Gelpi-Acosta C, Wendel T, Hagan H. Recruitment-adjusted estimates of HIV prevalence and risk among men who have sex with men: Effects of weighting venue-based sampling data. Publ Health Rep 2011;126:635–642.
   PubMed Web of Science ®Google Scholar
• MacKellar DA, Gallagher KM, Finlayson T, Sanchez T, Lansky A, Sullivan PS. Surveillance of HIV risk and prevention behaviors of men who have sex with men–A national application of venue-based, time-space sampling. Publ Health Rep 2007;122:39–47.
   PubMed Web of Science ®Google Scholar
• Palamar JJ, Salomone A, Vincenti M, Cleland CM. Detection of “bath salts” and other novel psychoactive substances in hair samples of ecstasy/MDMA/“Molly” users. Drug Alcohol Depend 2016;161:200–205.
   Google Scholar